{"groups":[{"description":"Participants were randomized to receive 6.0 mg/kg of DS-1062a.","id":"FG000","title":"DS-1062a 6.0 mg/kg"},{"description":"Participants were randomized to receive 75 mg/m\\^2 docetaxel.","id":"FG001","title":"Docetaxel 75 mg/m^2"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"213"},{"groupId":"FG001","numSubjects":"212"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Other"},{"reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"29"}],"type":"Withdrawal by Subject"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"299"},{"groupId":"FG001","numSubjects":"305"}],"comment":"\"Started\" signifies number of participants randomized","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"68"},{"groupId":"FG001","numSubjects":"62"}],"comment":"\"Complete\" signifies number of participants ongoing in study","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"231"},{"groupId":"FG001","numSubjects":"243"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"A total of 605 participants , including 1 participant who was randomized twice, were randomized to the study in Europe, Asia, North America, South America, and Australia."}